首页> 外文会议>International Conference on Environmental Science and Technology >ELIMINATION OF PHARMACEUTICAL RESIDUES IN HOSPITAL WASTEWATER USING LOW AND MEDIUM PRESSURE UV LAMPS
【24h】

ELIMINATION OF PHARMACEUTICAL RESIDUES IN HOSPITAL WASTEWATER USING LOW AND MEDIUM PRESSURE UV LAMPS

机译:使用低压紫外线灯消除医院废水中的药物残留物

获取原文

摘要

The current work aims at investigating the decentralised elimination of Pharmaceuticals from hospital wastewater. The research study involved a pilot-scale membrane bioreactor (MBR) being connected to a representative wastewater stream of a hospital. The MBR process served as efficient pre-treatment while macropollutants (e.g. organic carbon, nitrogen, suspended solids) are reduced before energy intensive UV treatment has been applied to tackle the pharmaceutical elimination of the MBR effluent. The continuously gained permeate (MBR effluent) was linked to a UV treatment unit which was run in batch operation. Low and medium pressure UV lamps were tested for their efficiency to remove Pharmaceuticals from the MBR permeate. Furthermore, the UV treatment was operated in combination with different dosages of H_2O_2 to establish an advanced oxidation process (AOP). The efficiency of the pharmaceutical removal process was assessed with 9 micropollutants (antibiotics, analgesics, anticonvulsants, cytostatics, lipid regulators) which are typically released by hospitals. Liquid chromatography coupled tandem mass spectrometry (LC-MS/MS) was applied for their detection. While the MBR treatment showed generally only low degradation capacity for persistent Pharmaceuticals (e.g. diurnal removal rate of 25 % for diclofenac) promising results were obtained by applying UV irradiation and H_2O_2 as AOP. Moreover, comparing the electrical energy need in relation to the pharmaceutical degradation caused by the medium and low pressure UV lamp the latter appeared to have a considerable advantage in cost-effectiveness.
机译:目前的工作旨在调查医院废水的分散消除药物。研究研究涉及一种试验型膜生物反应器(MBR)连接到医院代表性的废水流。在能量密集型紫外线治疗之前,MBR工艺用作高效预处理,同时宏观劳顿剂(例如有机碳,氮,悬浮固体)降低,以解决MBR流出物的药物消除药物消除。连续获得的渗透物(MBR流出物)与含有批次操作进行的UV处理单元连接。测试低和中压UV灯以效率从MBR渗透物中除去药物。此外,UV处理与不同剂量的H_2O_2组合操作,以建立高级氧化过程(AOP)。药物去除过程的效率用9种微量舒适剂(抗生素,镇痛药,抗惊厥药,细胞抑制学,脂质调节剂)评估,这些含量通常由医院释放。液相色谱偶联串联质谱(LC-MS / MS)被施加检测。虽然MBR处理通常仅显示持续药物的低降解能力(例如,DICLOFENAC的25%的昼夜去除率)通过施用紫外线辐照和H_2O_2作为AOP而获得了效果。此外,与由培养基和低压UV灯引起的药物降解相比,后者似乎具有相当大的优势的能量需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号